bf/NASDAQ:VRDN_icon.jpeg

COM:VIRIDIANTHERAPEUTICS

Viridian Therapeutics

  • Stock

USD

Last Close

19.62

22/11 21:00

Market Cap

783.10M

Beta: -

Volume Today

858.39K

Avg: -

  • name

    Viridian Therapeutics, Inc.
  • homepage url

    www.viridiantherapeutics.com
  • country

    USUnited States
  • employee count

    94
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    314K

Description

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeti...Show More

peer of